CROFT-LEOMINSTER INC - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 93 filers reported holding PARATEK PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 3.64 and the average weighting 0.7%.

Quarter-by-quarter ownership
CROFT-LEOMINSTER INC ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2017$241,000
-35.7%
10,000
-48.7%
0.06%
-36.0%
Q1 2017$375,000
+68.2%
19,500
+34.5%
0.09%
+71.2%
Q4 2016$223,000
+18.6%
14,5000.0%0.05%
+10.6%
Q3 2016$188,00014,5000.05%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Omega Fund Management, LLC 2,600,410$10,480,0003.34%
Roumell Asset Management, LLC 340,323$1,372,0003.14%
Abingworth LLP 1,041,131$4,185,0002.02%
ICM ASSET MANAGEMENT INC/WA 448,315$1,807,0001.48%
Trellus Management Company, LLC 147,055$593,0000.99%
Prosight Management, LP 450,000$1,814,0000.80%
ARMISTICE CAPITAL, LLC 2,268,000$9,140,0000.53%
Arbiter Partners Capital Management LLC 848,069$3,418,0000.50%
NEXPOINT ASSET MANAGEMENT, L.P. 966,493$3,895,0000.30%
GENERAL AMERICAN INVESTORS CO INC 644,323$2,597,0000.24%
View complete list of PARATEK PHARMACEUTICALS INC shareholders